← Back
$SNDX All transactions

Syndax Pharmaceuticals Inc

J

$ Value

$10K

Shares

1,226

Price

$8

Filed

Aug 7

Insider

Name

Goldan Keith A.

Title

Chief Financial Officer

CIK

0001495411

Roles

Officer

Transaction Details

Transaction Date

2025-07-31

Code

J

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

93,676

Footnotes

The Reporting Person is voluntarily filing this Form 4 to report the acquisition of 1,226 shares by the Reporting Person on 07/31/2025 pursuant to the Issuer's Employee Stock Purchase Plan.

Filing Info

Accession No.

0000950170-25-105258

Form Type

4

Issuer CIK

0001395937

Goldan Keith A.'s History

Date Ticker Type Value
2026-04-01 ABEO A $0
2026-02-09 SNDX $72K
2026-02-06 SNDX $43K
2026-02-04 SNDX A $0
2026-02-04 SNDX A $0
2026-02-04 SNDX A $2.4M
2026-01-30 SNDX J $10K
2025-12-01 SNDX G $0
2025-07-31 SNDX J $10K
2025-07-16 SNDX $12K

Other Insiders at SNDX (90d)

Insider Bought Sold Last
Podlesak Dennis 2026-02-04
Katkin Keith 2026-02-04
Legault Pierre 2026-02-04
Goldan Keith A.
Chief Financial Officer
$115K 2026-02-09
Metzger Michael A
Chief Executive Officer
$514K 2026-02-09
Huber Martin H. Jr. 2026-02-04
Jarrett Jennifer 2026-02-04
Rizo Aleksandra 2026-02-04
Botwood Nicholas A.J.
Head of R&D, CMO
2026-02-04